Biocelect Pty Ltd
🇦🇺Australia
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
TGA:6
Drug Approvals
Vaxchora Vibrio cholerae bacteria cells (CVD 103-HgR strain) 4 x 10^8 to 2 x 10^9 CFU suspension, powder for, sachet (389746)
- Product Name
- Vaxchora Vibrio cholerae bacteria cells (CVD 103-HgR strain) 4 x 10^8 to 2 x 10^9 CFU suspension, powder for, sachet
- Approval Date
- Sep 6, 2023
TGA
NUVAXOVID (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 VACCINE adjuvanted suspension for injection vial (355139)
- Product Name
- NUVAXOVID (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 VACCINE adjuvanted suspension for injection vial
- Approval Date
- Jan 20, 2022
TGA
VIVOTIF ORAL oral typhoid vaccine capsule blister pack (322340)
- Product Name
- VIVOTIF ORAL oral typhoid vaccine capsule blister pack
- Approval Date
- Nov 28, 2019
TGA
KODATEF tafenoquine (as succinate) 100 mg tablet blister pack (293438)
- Product Name
- KODATEF tafenoquine (as succinate) 100 mg tablet blister pack
- Approval Date
- Sep 19, 2018
TGA
RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial (285559)
- Product Name
- RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial
- Approval Date
- Mar 21, 2018
TGA
IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial (162215)
- Product Name
- IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial
- Approval Date
- Aug 23, 2010
TGA
Clinical Trials
No trials found
News
No news found